Cargando…

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension

To study patient and physician attitudes to pharmaceutical therapy and renal denervation for the management of hypertension. METHODS: Data were analyzed from 19 market research studies in Western Europe and the United States conducted between 2010 and 2019 to obtain quantitative and qualitative pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmieder, Roland E., Kandzari, David E., Wang, Tzung-Dau, Lee, Ying-Hsiang, Lazarus, Gabriel, Pathak, Atul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752236/ https://www.ncbi.nlm.nih.gov/pubmed/32773653 http://dx.doi.org/10.1097/HJH.0000000000002592

Ejemplares similares

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
por: Mathiassen, Ole N., et al.
Publicado: (2016)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry
por: Song, Jie, et al.
Publicado: (2016)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives
por: Schmieder, Roland E
Publicado: (2022)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Renal Denervation in Hypertensive Patients: Back to Anatomy?
por: Persu, Alexandre, et al.
Publicado: (2020)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation
por: Schmieder, Roland E., et al.
Publicado: (2016)

Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward
por: Wang, Tzung-Dau
Publicado: (2022)

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
por: Schumacher, Christoph D., et al.
Publicado: (2013)

Renal Nerve Stimulation Predicted Blood Pressure–Lowering Responses to Percutaneous Renal Denervation
por: Huang, Hui-Chun, et al.
Publicado: (2023)

Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study
por: Cremers, Anne L., et al.
Publicado: (2019)

Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012
por: Sengul, Sule, et al.
Publicado: (2016)

The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini‐review
por: Huang, Hui‐Chun, et al.
Publicado: (2022)

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China
por: Wang, Zengwu, et al.
Publicado: (2017)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial
por: Mancia, Giuseppe, et al.
Publicado: (2014)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension
por: Peacock, Erin, et al.
Publicado: (2021)

Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study
por: Yu, Esther Y.T., et al.
Publicado: (2017)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model
por: Cohen-Mazor, Meital, et al.
Publicado: (2014)

British Pharmaceutical Conference
Publicado: (1908)

Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment
por: Kandzari, David E., et al.
Publicado: (2022)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Renal denervation in hypertensive patients not on blood pressure lowering drugs
por: De Jager, Rosa L., et al.
Publicado: (2016)

Renal Sympathetic Denervation for Hypertension
por: Guber, Kenneth, et al.
Publicado: (2022)

Renal denervation for uncontrolled hypertension
por: Marcusohn, Erez, et al.
Publicado: (2023)

Renal Sympathetic Denervation for Resistant Hypertension Treatment - Current Perspectives
por: Brandão, Andréa Araujo, et al.
Publicado: (2013)

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Current perspectives in the management of treatment-resistant depression
por: Parikh, Rajesh M., et al.
Publicado: (2004)

Renal denervation as an option for the management of hypertension
por: Santiapillai, Georgina Radhini, et al.
Publicado: (2014)

Renal denervation for the management of resistant hypertension
por: Patel, Hitesh C, et al.
Publicado: (2015)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study
por: Stewart, Simon, et al.
Publicado: (2014)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Long-term effect of specific treatment of primary aldosteronism on carotid intima–media thickness
por: Holaj, Robert, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6c44pqsc7686neho2sop9ubka0